Cologne Bonn Region
I am a highly motivated team player with 20+ years experience in the healthcare sector covering statistics/biometry, HEOR and RWE generation with demonstrated history of strategic and tactical business achievements in various roles at global and local level across different therapeutic areas. Work experience in the US, Belgium and Germany. Successful track record in stakeholder engagement with a focus on digital innovation and real world insights generation including the US market. I am committed to ensure patient access to innovation in an ethical manner whilst acknowledging the impact on the wider business.
Lead development of cross-functional, integrated evidence generation strategy and plan for Thrombosis Franchise to - maximize portfolio value - optimize launch & RoI - accelerate development, access & adoption - apply RWE / AI-based innovation - shape RWE acceptability
Lead development of cross-functional, integrated evidence generation strategy and plan for Heart Failure Franchise to - maximize portfolio value - optimize launch & RoI - accelerate development, access & adoption - shape RWE acceptability
- Global Market Access - Director - Head Real World Insights early CV, Thrombosis, Cardio-Renal - Lead Real-Life Evidence (RLE) Excellence, Precision Medicine, Digital, AI, Innovation, study simulation - Ensure RWE-related Market Access requirements are considered throughout all development stages across therapeutic areas (early CV, Thrombosis, Cardio-Renal) - Responsible for defining therapeutic area RWE strategy, identification of evidence gaps and coordination of tactics to optimise positioning, value, pricing and reimbursement - Identification of innovative stakeholder collaboration models / RWE-focussed methodologies and assessment of respective HTA / Payer acceptability (e.g. virtual arm, surrogate endpoint, cross-design synthesis) - Development of concepts related to digital business models - HEOR representative in global decision making bodies